2COLLET J P, MONTALESCOT G,LISON L, et al.Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris[J]. Circulation , 2001,103:658- 663.
3FERGUSON J J, ANTMAN E M, BATES E R, etal. Combining enoxaparin and glycoprotein Ⅱb/Ⅲa antagonists for the treatmentof acute coronary syndromes: final results of the NICE 3 study[J]. Am Heart J ,2003,146: 628-634.
4GOODMAN S G, FITCHETT D, ARMSTRONG PW, et al. for the INTERACT Trial Investigators.The Integrilin and Enoxaparin Randomized Assessment of Acute Coronary syndrome Treatment (INTERACT) trial (abstr)[J]. J Am Coll Cardiol,2002,405:405
5YOUNG J J,KEREIAKES D J,GRINES C L.Lowmolecular-weight heparin therapy in percutaneous coronary intervention:the NICE 1 and NICE 4 trials[J].J Invas Cardiol,2000,12:18-25
6CHOUSSAT R,MONTALESCOT G,COLLET J P,et al.A unique,low dose of intravenrous enoxaparin in elective percutaneous coronary intervention[J].J Am Coll Cardiol,2002,40:19430-19450
7KARSCH KR,PREISACK MB,BONAN R,et al.Incidence,outcome and prediction of early clinical events following percutaneous transluminal coromary angioplasty:a comparison between treatment with reviparin and nfractionated heparin/placebo(results of a substudy of the REDUCE trial)[J].Eur Heart J,1998,19:1232-1238
8RABAH M M,PREMMEREUR J, GRAHAM M,et al.Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris[J].Am J Cardiol,1999,84:1391-1395
9FOX K,ANTMAN E,COHEN M,et al.Comparison of enoxaparin versus unfractionated heparin in pateints with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous intervention[J].Am J Cardiol,2002,90:477-482
10COHEN M,DEMERS C,GURFINKEL E P,et al.A comparison of low-molecular-weight heparins with unfractionated heparin for unstable coronary artery disease[J].N Engl J Med,1997,337:447-452
